These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9806352)

  • 1. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
    Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
    Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors.
    Anolik JH; Klinge CM; Brolly CL; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):413-29. PubMed ID: 9010347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
    Klinge CM; Traish AM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
    Anolik JH; Klinge CM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):713-30. PubMed ID: 8274405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.
    Klinge CM; Traish AM; Driscoll MD; Hilf R; Bambara RA
    Steroids; 1996 May; 61(5):278-89. PubMed ID: 8738832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand.
    Anolik JH; Klinge CM; Hilf R; Bambara RA
    Biochemistry; 1995 Feb; 34(8):2511-20. PubMed ID: 7873531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro.
    Klinge CM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1992 Oct; 43(4):249-62. PubMed ID: 1390277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression.
    Klinge CM
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):99-111. PubMed ID: 10411304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Footprint analysis of estrogen receptor binding to adjacent estrogen response elements.
    Driscoll MD; Klinge CM; Hilf R; Bambara RA
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):45-61. PubMed ID: 8809185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
    Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R
    J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
    Obrero M; Yu DV; Shapiro DJ
    J Biol Chem; 2002 Nov; 277(47):45695-703. PubMed ID: 12244117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro.
    Klinge CM; Brolly CL; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1997; 63(4-6):283-301. PubMed ID: 9459195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.
    Krieg AJ; Krieg SA; Ahn BS; Shapiro DJ
    J Biol Chem; 2004 Feb; 279(6):5025-34. PubMed ID: 14617632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo.
    Metzger D; Berry M; Ali S; Chambon P
    Mol Endocrinol; 1995 May; 9(5):579-91. PubMed ID: 7565805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.